SYS ONLINE
SUPPLEMENT_SCHOLAR
evidence · mechanism · dose
Experimental/Reproductive / HPGResearch peptide

Kisspeptin-10

Decapeptide fragment of kisspeptin that drives GnRH release and gates the reproductive axis.

Educational explainer of a research peptide. Profiles in this section deliberately omit clinical-trial citations, dosing protocols, and purchase links. Not FDA-approved as a supplement; not a recommendation to use.

Overview

Kisspeptin-10 is the active C-terminal fragment of kisspeptin, the hypothalamic peptide that controls GnRH neuron firing and therefore the entire HPG axis.

Source
  • Endogenously produced in hypothalamus
  • Synthesized for research
Forms
  • Subcutaneous or intravenous injection (clinical research)

Mechanism of action

Binds KISS1R (GPR54) on GnRH neurons, triggering GnRH release that drives LH and FSH from the pituitary.

Pathways
  • · KISS1R activation
  • · GnRH release
  • · LH/FSH pulse generation
Receptors
  • · KISS1R (GPR54)
Hormones
  • · GnRH
  • · LH
  • · FSH
  • · Testosterone
  • · Estradiol

How it acts on the body

Kisspeptin sits upstream of GnRH and is the master gate of the HPG axis — without it, puberty does not start and reproductive function collapses. Kisspeptin-10 is the minimal active fragment, suitable for clinical research dosing.

It is being studied as a more physiological alternative to hCG for triggering ovulation in IVF (less ovarian hyperstimulation risk), and as a probe for hypogonadism diagnosis. It does not bypass downstream feedback the way gonadotropins do, so net hormonal effects depend on intact pituitary and gonadal function.

Hormonal & endocrine impact

How this peptide is reported to shift specific hormones and signaling molecules. Directionality reflects research literature and preclinical models, not clinical prescribing data.

Projected hormonal trajectory
Illustrative curves derived from reported direction of effect. Not measured patient data.

Curves are schematic shapes (sigmoid for increases/decreases, damped oscillation for modulation/stabilization) anchored to a 100% baseline. They communicate direction and tempo of change reported in research literature — not absolute hormone concentrations.

GnRHIncreases
Direct upstream trigger of GnRH neurons.
LHIncreases
Pituitary LH pulse follows kisspeptin dosing.
FSHIncreases
Smaller pulse, but real.
Testosterone / EstradiolIncreases
Downstream gonadal response.

Effects on the body

Increases
GnRH and gonadotropin pulses
Supports
Physiological ovulation trigger
Optimizes
HPG axis testing

Organ system effects

Endocrine

Activates the entire HPG axis from hypothalamus down.

Reproductive

Drives gonadal hormone production.

Reported effects

Drawn from preclinical research, anecdote, and small-scale clinical observation. No evidence grades are assigned — most peptides on this page lack rigorous human trials.

  • Physiological IVF trigger with lower OHSS risk
  • Diagnostic probe for HPG function

Potential side effects

Common
  • · Flushing
  • · Headache
Rare
  • · Nausea
Serious
  • · Limited large-trial human data

Drug interactions

GnRH agonists or antagonists
Direct mechanism overlap.
moderate

Pairing context

Often combined with
  • Reproductive medicine specialist oversight
    Used in controlled IVF protocols.
Avoid combining with
  • Hormone-sensitive malignancy
    Activates the entire steroidogenesis cascade.
Important. Research peptides described here are not FDA-approved supplements. Supplement Scholar does not endorse, recommend, or link to any source for purchase. Consult a qualified clinician before considering any peptide therapy.